UrgoTouch’s® functionning

3 FACTORS DETERMINE THE QUALITY OF THE SCAR

surgical technique & suture

Controlled by the surgeon

Pre & post-operative care

Controlled by the patient

biological healing process

Uncontrolled

can be optimised by UrgoTouch®

Why is the scarring process result very unpredictable and random?

The scarring process takes place in 4 main phases during all of which growth factors (proteins that stimulate the growth of specific tissues) play a key role in organizing the healing process and orchestrating the recovery of the skin. It notably instructs other types of cells to start the production of collagen.

In order to obtain a aesthetic and sufficiently elastic scar, the molecular concentration must be appropriately regulated to ensure a good balance between the synthesis of :

Type I collagen: thicker, more rigid
Type III collagen: thinner, more flexible, essential to aesthetics and elasticity of the scar

If the mollecular concentration is not balanced, the production of Collagen Type I will overpower Collagene Type III, resulting in a more fibrotic and less elastic scar, and in a risk of having an unaesthetic and problematic scar.

How does UrgoTouch® optimize the scarring process?

UrgoTouch® is a laser technology that has been demonstrated through various published clinical studies and cases and has proven to decrease the scars volume by up to 53%.**

It can be used on all skin phototypes (I to VI)

It requires 1 single session in the operating room at the end of any body surgery.*

UrgoTouch® induces a 50°C temperature on the surface of the skin, right on the suture to safely activate Heat shock protein HSP70, which aims at protecting skin cells from damages caused by overly high temperatures.

Recent experimental studies demonstrated that HSP70, which is over-expressed following laser irradiation, could play a role in the modulation of the inflammatory reponse. Thus it may reduce the production of type I collagen as well as inflammatory molecules, leading to improved healing results for patients.***

Studies have shown that UrgoTouch® optimizes the scar aspect by reducing the randomness and highly unpredictable outcomes in the healing process associated with this molecular pathway.

*Contraindication for face and cancer

**A 1 Year Follow-up of Post-operative Scars After the Use of a 1210nm Laser Assisted Skin Healing (LASH) Technology: A Randomized Controlled Trial. D.Casanova, ed. Aesthetic Plastic Surgery Journal. Feb 2017 – Reduction of 53% observed in a patient with dark phototype

***Mordon S, Capon A, et al. Lasers thermiques et cicatrisation cutanée. Med Sci (Paris). 2010 Jan

What is the difference between uRGOTOUCH and other lasers dedicated to scar optimization?

UrgoTouch is the only laser dedicated to scar optimization that is used in the operating room directly after suturing (allowing it to act from the very beginning of the initial healing phase) and requires only one session.

What is the price of the treatment?

Your doctor will inform you of the cost of the UrgoTouch® treatment during your consultation.

What are the contraindications?

Only your surgeon will be able to determine if the UrgoTouch ®procedure is suitable for your case.

Can the laser be used on all skin types?

The UrgoTouch ® laser can be used on all phototypes.

At what point during the operation is the laser used?

The UrgoTouch® laser requires a single application in the operating room when the patient is under anesthesia. It is performed at the end of the surgical procedure, once the surgeon has completed the suturing.

Does the use present any risks?

Some non-specific undesirable events may occur, regardless of the laser, after any surgical procedure involving an incision of the skin.

Additionally, some local undesirable events specific to the use of any non-ablative laser may also be observed.

How many patients have benefited from the laser?

Today, more than thirty thousand patients have already benefited from the UrgoTouch® laser.

FIND A SURGEON